These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 5539443)
21. [Biochemical diagnosis of pheochromocytoma, neuroblastoma and other neuro-ectodermal neoplasms]. Käser H Helv Paediatr Acta; 1972; 29():Suppl 29:1-114. PubMed ID: 4661091 [No Abstract] [Full Text] [Related]
22. [Studies on the excretion of catecholamines and their degradation products in hypertension and pheochromocytoma]. Clotten R; Michaelis J Klin Wochenschr; 1966 Oct; 44(20):1161-71. PubMed ID: 5995155 [No Abstract] [Full Text] [Related]
23. Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy. Routh JI; Bannow RE; Fincham RW; Stoll JL Clin Chem; 1971 Sep; 17(9):867-71. PubMed ID: 5571485 [No Abstract] [Full Text] [Related]
24. [Urinary excretion of adrenaline, noradrenaline and vanilmandelic acid in adolescents with primary arterial hypertension]. Markov KhM; Nebol'sina LI Klin Med (Mosk); 1973 Sep; 51(9):33-8. PubMed ID: 4791338 [No Abstract] [Full Text] [Related]
25. The influence of the dopa decarboxylase inhibitor Ro4-4602 on the urinary excretion of catecholamines in cold-stressed rats. Johnson GE; Pritzker K J Pharmacol Exp Ther; 1966 Jun; 152(3):432-8. PubMed ID: 5922312 [No Abstract] [Full Text] [Related]
26. Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues. Romero JA; Lytle LD; Ordonez LA; Wurtman RJ J Pharmacol Exp Ther; 1973 Jan; 184(1):67-72. PubMed ID: 4686016 [No Abstract] [Full Text] [Related]
27. [The excretion of adrenaline, noradrenaline and their precursors (DOPA and dopamine) in migraine patients]. Gol'dman NB; Matlina ESh; Fets AN Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(2):199-203. PubMed ID: 5439831 [No Abstract] [Full Text] [Related]
28. Pheochromocytoma of the urinary bladder, with inconclusive chemical and pharmacologic tests. Bogaert MG; Vermeulen A Am J Med; 1972 Dec; 53(6):797-800. PubMed ID: 4634733 [No Abstract] [Full Text] [Related]
29. Hyperexcretion of cathecholamines induced by indomethacine. Stjärne L Acta Physiol Scand; 1971 Dec; 83(4):574-6. PubMed ID: 5003641 [No Abstract] [Full Text] [Related]
30. [Assessment of the functional state and sympatho-adrenal system by dopamine and dopa excretion in the urine]. Matlina ESh; Gugutishvili TsG; Kiseleva ZM; Kolesova DV; Sofieva IE Probl Endokrinol (Mosk); 1968; 14(1):15-9. PubMed ID: 5736988 [No Abstract] [Full Text] [Related]
31. [Efficacy and limits of diagnostic procedures in hypertension]. Jahnecke J Internist (Berl); 1974 Mar; 15(3):132-8. PubMed ID: 4365320 [No Abstract] [Full Text] [Related]
32. [The effect of guanethidine upon the diurnal rhythm of cathecholamines, dopa and dopamine in patients with hypertension]. Vishnepol'skiĭ IuIa Sov Med; 1969 Jan; 32(1):52-6. PubMed ID: 5385216 [No Abstract] [Full Text] [Related]
33. Dihydroxyphenylalanine secretion in a malignant pheochromocytoma. Anton AH; Greer M; Sayre DF; Williams CM Am J Med; 1967 Mar; 42(3):469-75. PubMed ID: 6018863 [No Abstract] [Full Text] [Related]
34. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography]. Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503 [No Abstract] [Full Text] [Related]
35. [Urinary catecholamine excretion in arterial hypertension]. Kedra M; Gryglewska I; Woyda J Pol Tyg Lek; 1972 Feb; 27(7):250-4. PubMed ID: 5011600 [No Abstract] [Full Text] [Related]
36. Study of some biological indices of the state of the sympathoadrenaline system under the effect of polychlorocamphene. Kuz'minskaya UA; Ivanitskiĭ VA Environ Health Perspect; 1979 Jun; 30():91-5. PubMed ID: 446464 [TBL] [Abstract][Full Text] [Related]
37. [Excretion of dopamine (DA), noradrenaline (NA), adrenaline (A) and 3-methoxy-4-hydroxymandelic acid (KMHM) in the urine of patients with essential hypertension]. Stelmasiak T; Sodolski W; Szewczykowski W; Sikorska W Pol Arch Med Wewn; 1974 Sep; 52(3):291-8. PubMed ID: 4423765 [No Abstract] [Full Text] [Related]
38. [The state of the sympathetico-adrenal system in the development of hypertension]. Speranskiĭ MD Kardiologiia; 1967 Mar; 7(3):24-6. PubMed ID: 5604604 [No Abstract] [Full Text] [Related]
39. [Role of the sympathico-adrenal system in the pathogenesis of hypertensive disease]. Shvatsabaia IK; Kiseleva ZM Kardiologiia; 1974 Aug; 14(8):42-6. PubMed ID: 4431161 [No Abstract] [Full Text] [Related]
40. Changes in the excretion of catecholamines and their metabolites in patients with essential hypertension during sodium intake restriction. Wocial B; Januszewicz W; Chodakowska J; Feltynowski T Cor Vasa; 1981; 23(3):222-8. PubMed ID: 6790225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]